VALIGEN

OLIGONUCLEOTIDES FOR INTRODUCING SITE SPECIFIC MUTATIONS IN A CELL

PHARMACEUTICAL PREPARATIONS CONTAINING A CARRIER FOR THE IN VIVO DELIVERY TO HEPATOCYTES OF OLIGONUCLEOTIDES THAT CAN ALTER A GENE OF THE HEPATOCYTE FOR THE PURPOSE OF TREATING GENETIC DEFECTS, METABOLIC DISORDERS, INFECTIOUS DISEASES AND NEOPLASTIC DISEASES

GENETICALLY MODIFIED ANIMAL ORGANS FOR IMPLANTATION INTO HUMANS

GENETICALLY MODIFIED LIVING PLANTS, LIVE RODENTS, AND VIABLE PLANT SEEDS

COMPUTERIZED GENOME DATABASE MANAGEMENT FOR DRUG DISCOVERY

MANUFACTURE OF GENETICALLY MODIFIED RODENTS, PLANTS AND SEEDS MADE TO THE ORDER AND SPECIFICATION OF OTHERS; MANUFACTURE OF GENETICALLY MODIFIED ANIMAL ORGANS FOR IMPLANTATION INTO HUMANS MADE TO THE ORDER AND SPECIFICATION OF OTHERS, MANUFACTURE OF OLIGONUCLEOTIDES FOR INTRODUCING SITE SPECIFIC MUTATIONS IN A CELL MADE TO THE ORDER AND SPECIFICATION OF OTHERS

DEVELOPMENT OF GENETIC INTERVENTION PRODUCTS FOR APPLICATIONS SUCH AS DRUG DISCOVERY, DIAGNOSTICS, AGRONOMIC BIOLOGICAL ENGINEERING, GENOMIC RESEARCH, NAMELY, DEVELOPING, COMPILING AND SUPPLYING TO OTHERS SPECIALTY IDENTIFICATION OF GENES, POPULATION-BASED IDENTIFICATION OF DISEASE-ASSOCIATED GENES, GENE MUTATION SCREENING AND DEVELOPMENT OF DATABASES